Considerations for hormonal therapy in migraine patients: a critical review of current practice

References

• GBD. 2019 Diseases and injuries collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020 Oct 17;396(10258):1204–1222.
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1–211. doi: 10.1177/0333102417738202
   PubMed Web of Science ®Google Scholar
• Stovner LJ, Nichols E, Steiner TJ, et al. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018;17(11):954–976. doi: 10.1016/S1474-4422(18)30322-3
   PubMed Web of Science ®Google Scholar
• Vetvik KG, MacGregor EA. Menstrual migraine: a distinct disorder needing greater recognition. Lancet Neurol. 2021 Apr;20(4):304–315. doi: 10.1016/S1474-4422(20)30482-8
   PubMed Web of Science ®Google Scholar
• Ceriani CEJ, Silberstein SD. Current and emerging pharmacotherapy for menstrual migraine: a narrative review. Expert Opin Pharmacother. 2023 Apr;24(5):617–627. doi: 10.1080/14656566.2023.2194487
   PubMed Web of Science ®Google Scholar
• Maasumi K, Tepper SJ, Kriegler JS. Menstrual migraine and treatment options: review. Headache. 2017;57(2):194–208. doi: 10.1111/head.12978
   PubMed Web of Science ®Google Scholar
• Verhagen IE, Spaink HA, van der Arend BW, et al. Validation of diagnostic ICHD-3 criteria for menstrual migraine. Cephalalgia. 2022 Oct;42(11–12):1184–1193. doi: 10.1177/03331024221099031
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993 Jan;33(1):48–56. doi: 10.1002/ana.410330109
   PubMed Web of Science ®Google Scholar
• Russell FA, King R, Smillie SJ, et al. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014 Oct;94(4):1099–1142.
   PubMed Web of Science ®Google Scholar
• Bentivegna E, Luciani M, Scarso F, et al. Hormonal therapies in migraine management: current perspectives on patient selection and risk management. Expert Rev Neurother. 2021 Dec;21(12):1347–1355.
   PubMed Web of Science ®Google Scholar
• Lyall M, de Oliveira BR, Mody SK. Considerations for contraceptive use among patients with migraines. Curr Obstet Gynecol Rep. 2023 Jun 1;12(2):57–63. doi: 10.1007/s13669-023-00349-8
   Web of Science ®Google Scholar
• Sacco S, Merki-Feld GS, Ægidius KL, et al. Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European headache Federation (EHF) and the European Society of contraception and reproductive Health (ESCRH). J Headache Pain [Internet]. 2018;19(1).doi: 10.1186/s10194-018-0896-5
   Google Scholar
• Ornello R, De Matteis E, Di Felice C, et al. Acute and preventive management of migraine during menstruation and menopause. J Clin Med Res [Internet]. 2021 May 24;10(11): 2263. doi: 10.3390/jcm10112263.
   Google Scholar
• Sullivan E, Bushnell C. Management of menstrual migraine: a review of current abortive and prophylactic therapies. Curr Pain Headache Rep. 2010 Oct;14(5):376–384. doi: 10.1007/s11916-010-0138-2
   PubMed Web of Science ®Google Scholar
• MacGregor EA. Menstrual and perimenopausal migraine: A narrative review. Maturitas. 2020 Dec;142:24–30. doi: 10.1016/j.maturitas.2020.07.005
   PubMed Web of Science ®Google Scholar
• Ansari T, Lagman-Bartolome AM, Monsour D, et al. Management of menstrual migraine. Curr Neurol Neurosci Rep. 2020 Aug 8;20(10):45. doi: 10.1007/s11910-020-01067-x
   PubMed Web of Science ®Google Scholar
• Afridi SK. Migraine: navigating the hormonal minefield. Pract Neurol [Internet]. 2019;20(2):115–121.
   PubMedGoogle Scholar
• Hipolito Rodrigues MA, Maitrot-Mantelet L, Plu-Bureau G, et al. Migraine, hormones and the menopausal transition. Climacteric. 2018;21(3):256–266. doi: 10.1080/13697137.2018.1439914
   PubMed Web of Science ®Google Scholar
• Allais G, Chiarle G, Sinigaglia S, et al. Menstrual migraine: a review of current and developing pharmacotherapies for women. Expert Opin Pharmacother. 2018;19(2):123–136. doi: 10.1080/14656566.2017.1414182
   PubMed Web of Science ®Google Scholar
• Allais G, Chiarle G, Sinigaglia S, et al. Treating migraine with contraceptives. Neurol Sci. 2017;38(S1):85–89. doi: 10.1007/s10072-017-2906-9
   PubMedGoogle Scholar
• Al-Hassany L, Haas J, Piccininni M, et al. Giving researchers a headache - sex and gender differences in migraine. Front Neurol. 2020 Oct 22;11:549038. doi: 10.3389/fneur.2020.549038
   PubMed Web of Science ®Google Scholar
• MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology. 2004 Jul 27;63(2):351–353. doi: 10.1212/01.WNL.0000133134.68143.2E
   PubMed Web of Science ®Google Scholar
• Thiyagarajan DK, Basit H, Jeanmonod R. Physiology, menstrual cycle. In: StatPearls [internet]. Treasure Island (FL): StatPearls Publishing. 2023 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK500020/
   Google Scholar
• Reddy N, Desai MN, Schoenbrunner A, et al. The complex relationship between estrogen and migraines: a scoping review. Syst Rev. 2021 Mar 10;10(1):72. doi: 10.1186/s13643-021-01618-4
   PubMed Web of Science ®Google Scholar
• Martin VT, Lipton RB. Epidemiology and biology of menstrual migraine. Headache. 2008 Nov;48(Suppl 3):S124–30. doi: 10.1111/j.1526-4610.2008.01310.x
   PubMedGoogle Scholar
• MacGregor EA, Frith A, Ellis J, et al. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology. 2006 Dec 26;67(12):2154–2158. doi: 10.1212/01.wnl.0000233888.18228.19
   PubMed Web of Science ®Google Scholar
• MacGregor EA. Menstruation, sex hormones, and migraine. Neurol Clin. 1997 Feb;15(1):125–141. doi: 10.1016/S0733-8619(05)70299-1
   PubMed Web of Science ®Google Scholar
• Faubion SS, Batur P, Calhoun AH. Migraine throughout the female reproductive life cycle. Mayo Clin Proc. 2018;93(5):639–645. doi: 10.1016/j.mayocp.2017.11.027
   PubMed Web of Science ®Google Scholar
• Kvisvik EV, Stovner LJ, Helde G, et al. Headache and migraine during pregnancy and puerperium: the MIGRA-study. J Headache Pain. 2011 Aug;12(4):443–451.
   PubMed Web of Science ®Google Scholar
• MacGregor EA. Migraine, menopause and hormone replacement therapy. Post Reprod Health. 2018;24(1):11–18. doi: 10.1177/2053369117731172
   PubMedGoogle Scholar
• Delaruelle Z, Ivanova TA, Khan S, et al. Male and female sex hormones in primary headaches. J Headache Pain [Internet]. 2018;19(1. doi: 10.1186/s10194-018-0922-7
   PubMedGoogle Scholar
• Labastida-Ramírez A, Rubio-Beltrán E, Villalón CM, et al. Gender aspects of CGRP in migraine. Cephalalgia. 2019;39(3):435–444. doi: 10.1177/0333102417739584
   PubMed Web of Science ®Google Scholar
• Valdemarsson S, Edvinsson L, Hedner P, et al. Hormonal influence on calcitonin gene-related peptide in man: effects of sex difference and contraceptive pills. Scand J Clin Lab Invest. 1990 Jun;50(4):385–388.
   PubMed Web of Science ®Google Scholar
• Raffaelli B, Storch E, Overeem LH, et al. Sex hormones and calcitonin gene-related peptide in women with migraine: a cross-sectional, matched cohort study. Neurology. 2023 Apr 25;100(17):e1825–35. doi: 10.1212/WNL.0000000000207114
   PubMed Web of Science ®Google Scholar
• Pavlović JM, Allshouse AA, Santoro NF, et al. Sex hormones in women with and without migraine: evidence of migraine-specific hormone profiles. Neurology. 2016 Jul 5;87(1):49–56. doi: 10.1212/WNL.0000000000002798
   PubMed Web of Science ®Google Scholar
• Ibrahimi K, van Oosterhout WPJ, van Dorp W, et al. Reduced trigeminovascular cyclicity in patients with menstrually related migraine. Neurology. 2015 Jan 13;84(2):125–131. doi: 10.1212/WNL.0000000000001142
   PubMed Web of Science ®Google Scholar
• van Oosterhout WPJ, Schoonman GG, van Zwet EW, et al. Female sex hormones in men with migraine. Neurology. 2018;91(4):e374–81. doi: 10.1212/WNL.0000000000005855
   PubMed Web of Science ®Google Scholar
• Pringsheim T, Gooren L. Migraine prevalence in male to female transsexuals on hormone therapy. Neurology. 2004 Aug 10;63(3):593–594. doi: 10.1212/01.WNL.0000130338.62037.CC.
   PubMed Web of Science ®Google Scholar
• MacGregor A. Estrogen replacement and migraine aura. Headache. 1999 Oct;39(9):674–678. doi: 10.1046/j.1526-4610.1999.3909674.x
   PubMedGoogle Scholar
• Gupta S, McCarson KE, Welch KMA, et al. Mechanisms of pain modulation by sex hormones in migraine. Headache. 2011 Jun;51(6):905–922.
   PubMed Web of Science ®Google Scholar
• Jayaraman A, Pike CJ. Progesterone attenuates oestrogen neuroprotection via downregulation of oestrogen receptor expression in cultured neurones. J Neuroendocrinol. 2009 Jan;21(1):77–81. doi: 10.1111/j.1365-2826.2008.01801.x
   PubMed Web of Science ®Google Scholar
• Draper CF, Duisters K, Weger B, et al. Menstrual cycle rhythmicity: metabolic patterns in healthy women. Sci Rep. 2018 Oct 1;8(1):14568. doi: 10.1038/s41598-018-32647-0
   PubMedGoogle Scholar
• Krause DN, Warfvinge K, Haanes KA, et al. Hormonal influences in migraine - interactions of oestrogen, oxytocin and CGRP. Nat Rev Neurol. 2021 Oct;17(10):621–633. doi: 10.1038/s41582-021-00544-2
   PubMed Web of Science ®Google Scholar
• Somerville BW. The influence of progesterone and estradiol upon migraine. Headache. 1972 Oct;12(3):93–102. doi: 10.1111/j.1526-4610.1972.hed1203093.x
   PubMed Web of Science ®Google Scholar
• Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology. 1972 Apr;22(4):355–365. doi: 10.1212/WNL.22.4.355
   PubMed Web of Science ®Google Scholar
• Hornung RS, Benton WL, Tongkhuya S, et al. Progesterone and allopregnanolone rapidly attenuate estrogen-associated mechanical allodynia in rats with persistent temporomandibular joint inflammation. Front Integr Neurosci. 2020 May 8;14:26. doi: 10.3389/fnint.2020.00026
   PubMed Web of Science ®Google Scholar
• Coronel MF, Labombarda F, González SL. Neuroactive steroids, nociception and neuropathic pain: a flashback to go forward. Steroids. 2016 Jun;110:77–87. doi: 10.1016/j.steroids.2016.04.005
   PubMed Web of Science ®Google Scholar
• Glaser R, Dimitrakakis C, Trimble N, et al. Testosterone pellet implants and migraine headaches: a pilot study. Maturitas. 2012 Apr;71(4):385–388. doi: 10.1016/j.maturitas.2012.01.006
   PubMed Web of Science ®Google Scholar
• Herring MJ, Oskui PM, Hale SL, et al. Testosterone and the cardiovascular system: a comprehensive review of the basic science literature. J Am Heart Assoc. 2013 Jul 10;2(4):e000271. doi: 10.1161/JAHA.113.000271
   PubMed Web of Science ®Google Scholar
• Kobus M, Sitek A, Antoszewski B, et al. Prenatal oestrogen-testosterone balance as a risk factor of migraine in adults. J Headache Pain. 2021 Oct 7;22(1):119. doi: 10.1186/s10194-021-01326-3
   PubMed Web of Science ®Google Scholar
• Eikermann-Haerter K, Baum MJ, Ferrari MD, et al. Androgenic suppression of spreading depression in familial hemiplegic migraine type 1 mutant mice. Ann Neurol. 2009 Oct;66(4):564–568. doi: 10.1002/ana.21779
   PubMed Web of Science ®Google Scholar
• Perfalk E, da Cunha-Bang S, Holst KK, et al. Testosterone levels in healthy men correlate negatively with serotonin 4 receptor binding. Psychoneuroendocrinology. 2017 Jul;81:22–28.
   PubMed Web of Science ®Google Scholar
• Mattsson P. Serum levels of androgens and migraine in postmenopausal women. Clin sci. 2002 Nov;103(5):487–491. doi: 10.1042/cs1030487
   Web of Science ®Google Scholar
• Shields LBE, Seifert T, Shelton BJ, et al. Testosterone levels in men with chronic migraine. Neurol Int [Internet]. 2019;11(2). doi: 10.4081/ni.2019.8079
   Google Scholar
• Murray SC, Muse KN. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and “add-back” therapy. Fertil Steril. 1997 Feb;67(2):390–393. doi: 10.1016/S0015-0282(97)81928-0
   PubMed Web of Science ®Google Scholar
• Mikhael S, Punjala-Patel A, Gavrilova-Jordan L. Hypothalamic-pituitary-ovarian axis disorders impacting female fertility. Biomedicines [Internet]. 2019 Jan 4.7(1):5. doi: 10.3390/biomedicines7010005
   PubMed Web of Science ®Google Scholar
• Marques P, Skorupskaite K, Rozario KS, et al. Physiology of GnRH and gonadotropin secretion. In: Feingold K, Anawalt B, Blackman M, et al, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc; 2000 https://www.ncbi.nlm.nih.gov/books/NBK279070/.
   Google Scholar
• Facchinetti F, Sances G, Volpe A, et al. Hypothalamus pituitary-ovarian axis in menstrual migraine: effect of dihydroergotamine retard prophylactic treatment. Cephalalgia. 1983 Aug 1;3(1_suppl):159–162. doi: 10.1177/03331024830030S126
   PubMedGoogle Scholar
• Merki-Feld GS, Imthurn B, Gantenbein AR, et al. Effect of desogestrel 75 µg on headache frequency and intensity in women with migraine: a prospective controlled trial. Eur J Contracept Reprod Health Care. 2019;24(3):175–181. doi: 10.1080/13625187.2019.1605504
   PubMed Web of Science ®Google Scholar
• Aegidius K, Zwart JA, Hagen K, et al. Oral contraceptives and increased headache prevalence: the head-HUNT study. Neurology. 2006 Feb 14;66(3):349–353. doi: 10.1212/01.wnl.0000196481.57994.09
   PubMed Web of Science ®Google Scholar
• Warhurst S, Rofe CJ, Brew BJ, et al. Effectiveness of the progestin-only pill for migraine treatment in women: a systematic review and meta-analysis. Cephalalgia. 2018;38(4):754–764. doi: 10.1177/0333102417710636
   PubMed Web of Science ®Google Scholar
• Lieba-Samal D, Wöber C, Frantal S, et al. Headache, menstruation and combined oral contraceptives: a diary study in 184 women with migraine. Eur J Pain. 2011 Sep;15(8):852–857.
   PubMed Web of Science ®Google Scholar
• De Leo V, Scolaro V, Musacchio MC, et al. Combined oral contraceptives in women with menstrual migraine without aura. Fertil Steril. 2011 Oct;96(4):917–920.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Terreno E, Sances G, et al. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM). Contraception. 2013 Sep;88(3):369–375.
   PubMed Web of Science ®Google Scholar
• Sulak P, Willis S, Kuehl T, et al. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache. 2007 Jan;47(1):27–37.
   PubMed Web of Science ®Google Scholar
• Coffee AL, Sulak PJ, Hill AJ, et al. Extended cycle combined oral contraceptives and prophylactic frovatriptan during the hormone-free interval in women with menstrual-related migraines. J Womens Health. 2014 Apr;23(4):310–317.
   PubMed Web of Science ®Google Scholar
• Calhoun AH. A novel specific prophylaxis for menstrual-associated migraine. South Med J. 2004 Sep;97(9):819–822. doi: 10.1097/01.SMJ.0000129924.15619.D9
   PubMed Web of Science ®Google Scholar
• Nappi RE, Sances G, Sommacal A, et al. Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches. Menopause. 2006 Sep;13(5):818–825
   PubMed Web of Science ®Google Scholar
• Misakian AL, Langer RD, Bensenor IM, et al. Postmenopausal hormone therapy and migraine headache. J Womens Health. 2003 Dec;12(10):1027–1036. doi: 10.1089/154099903322643956
   Web of Science ®Google Scholar
• Kim S, Lee SB, Hong YJ, et al. The influence of endogenous and exogenous hormonal factors on migraine in spontaneous postmenopausal women: a nationwide population-based study in South Korea. Cephalalgia. 2022 Apr;42(4–5):376–384. doi: 10.1177/03331024211044441
   PubMed Web of Science ®Google Scholar
• Vetvik KG, MacGregor EA, Lundqvist C, et al. Contraceptive-induced amenorrhoea leads to reduced migraine frequency in women with menstrual migraine without aura. J Headache Pain. 2014 May 17;15(1):30. doi: 10.1186/1129-2377-15-30
   PubMedGoogle Scholar
• Almén-Christensson A, Hammar M, Lindh-Åstrand L, et al. Prevention of menstrual migraine with perimenstrual transdermal 17-β-estradiol: a randomized, placebo-controlled, double-blind crossover study. Fertil Steril. 2011 Aug;96(2):498–500.e1.
   PubMed Web of Science ®Google Scholar
• Dennerstein L, Morse C, Burrows G, et al. Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol. 1988 Jun;2(2):113–120.
   PubMed Web of Science ®Google Scholar
• de Lignières B, Vincens M, Mauvais-Jarvis P, et al. Prevention of menstrual migraine by percutaneous oestradiol. Br Med J. 1986 Dec 13;293(6561):1540. doi: 10.1136/bmj.293.6561.1540
   PubMedGoogle Scholar
• MacGregor EA, Frith A, Ellis J, et al. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology. 2006 Dec 26;67(12):2159–2163. doi: 10.1212/01.wnl.0000249114.52802.55
   PubMed Web of Science ®Google Scholar
• Calhoun A, Ford S, Pruitt A. The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series. Headache. 2012 Sep;52(8):1246–1253. doi: 10.1111/j.1526-4610.2012.02211.x
   PubMed Web of Science ®Google Scholar
• Magos AL, Zilkha KJ, Studd JW. Treatment of menstrual migraine by oestradiol implants. J Neurol Neurosurg Psychiatry. 1983 Nov;46(11):1044–1046. doi: 10.1136/jnnp.46.11.1044
   PubMed Web of Science ®Google Scholar
• CYH N, Tan BYQ, Teo YN, et al. Myocardial infarction, stroke and cardiovascular mortality among migraine patients: a systematic review and meta-analysis. J Neurol. 2022 May;269(5):2346–2358.
   PubMed Web of Science ®Google Scholar
• Schürks M, Rist PM, Bigal ME, et al. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009 Oct 27;339(oct27 1):b3914. doi: 10.1136/bmj.b3914
   PubMedGoogle Scholar
• Zhang S, Liu H, Shi T. Association between migraine and risk of stroke: a systematic review and meta-analysis. Neurol Sci. 2022 Aug;43(8):4875–4889. doi: 10.1007/s10072-022-06074-z
   PubMed Web of Science ®Google Scholar
• Champaloux SW, Tepper NK, Monsour M, et al. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol. 2017;216(5):e489.1–.e489.7. doi: 10.1016/j.ajog.2016.12.019
   Web of Science ®Google Scholar
• Kurth T. The association of migraine with ischemic stroke. Curr Neurol Neurosci Rep. 2010 Mar;10(2):133–139. doi: 10.1007/s11910-010-0098-2
   PubMed Web of Science ®Google Scholar
• Grimes DA, Lopez LM, O’Brien PA, et al. Progestin‐only pills for contraception. Cochrane Database Syst Rev [Internet]. 2013.(11). doi: 10.1002/14651858.CD007541.pub3
   Web of Science ®Google Scholar
• Sacco S, Merki-Feld GS, Ægidius KL, et al. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European headache Federation (EHF) and the European Society of contraception and Reproductive Health (ESC). J Headache Pain. 2017 Oct 30;18(1):108. doi: 10.1186/s10194-017-0815-1
   PubMedGoogle Scholar
• Shrader SP, Dickerson LM. Extended- and continuous-cycle oral contraceptives. Pharmacotherapy. 2008 Aug;28(8):1033–1040. doi: 10.1592/phco.28.8.1033
   PubMed Web of Science ®Google Scholar
• Allais G, Gabellari IC, Airola G, et al. Headache induced by the use of combined oral contraceptives. Neurol Sci. 2009 May;30(Suppl 1):S15–7. doi: 10.1007/s10072-009-0051-9
   PubMedGoogle Scholar
• Stegeman BH, de Bastos M, Rosendaal FR, et al. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ. 2013 Sep 12;347(sep12 1):f5298. doi: 10.1136/bmj.f5298
   PubMedGoogle Scholar
• LUMC. Migraine WHAT! study: woman, hormones, attacks, and treatment [Internet]. [cited 2023 Oct 2]. Available from: https://whatstudy.nl/en/.
   Google Scholar
• Clinicaltrials.gov. ID: NCT04007874. Migraine WHAT! study: woman, hormones, attacks, and treatment [Internet]. [cited 2023 Oct 2]. Available from: https://clinicaltrials.gov/study/NCT04007874.
   Google Scholar
• Cameron CR, Cohen S, Sewell K, et al. The art of hormone replacement therapy (HRT) in menopause management. J Pharm Pract. 2023 Apr 1;8971900231167925:089719002311679. doi: 10.1177/08971900231167925
   Google Scholar
• Facchinetti F, Nappi RE, Tirelli A, et al. Hormone supplementation differently affects migraine in postmenopausal women. Headache. 2002 Oct;42(9):924–929. doi: 10.1046/j.1526-4610.2002.02215.x
   PubMed Web of Science ®Google Scholar
• Rossouw JE, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s Health initiative randomized controlled trial. JAMA: The Journal Of The American Medical Association. 2002 Jul 17;288(3):321–333. doi: 10.1001/jama.288.3.321
   PubMed Web of Science ®Google Scholar
• Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. BMJ. 2020 Oct 28;371:m3873. doi: 10.1136/bmj.m3873
   PubMedGoogle Scholar
• Manson JE, Aragaki AK, Rossouw JE, et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the women’s Health initiative randomized trials. JAMA. 2017 Sep 12;318(10):927–938. doi: 10.1001/jama.2017.11217
   PubMed Web of Science ®Google Scholar
• Anderson GL, Chlebowski RT, Aragaki AK, et al. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the women’s Health initiative randomised placebo-controlled trial. Lancet Oncol. 2012 May;13(5):476–486.
   PubMed Web of Science ®Google Scholar
• MacGregor EA. Perimenopausal migraine in women with vasomotor symptoms. Maturitas. 2012 Jan;71(1):79–82. doi: 10.1016/j.maturitas.2011.11.001
   PubMed Web of Science ®Google Scholar
• Balfour JA, Heel RC. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints. Drugs. 1990 Oct;40(4):561–582. doi: 10.2165/00003495-199040040-00006
   PubMed Web of Science ®Google Scholar
• Kerns J, Darney P. Vaginal ring contraception. Contraception. 2011 Feb;83(2):107–115. doi: 10.1016/j.contraception.2010.07.008
   PubMed Web of Science ®Google Scholar
• Dixit A, Carden N, Stephens E, et al. Hormone replacement therapy subcutaneous implants for refractory menopause symptoms; the patient’s perspective. Post Reprod Health. 2022 Jun;28(2):79–91. doi: 10.1177/20533691221097042
   PubMedGoogle Scholar
• Garner C. Uses of GnRH agonists. J Obstet Gynecol Neonatal Nurs. 1994 Sep;23(7):563–570. doi: 10.1111/j.1552-6909.1994.tb01922.x
   PubMedGoogle Scholar
• Schriock ED. GnRH agonists. Clin Obstet Gynecol. 1989 Sep;32(3):550–563. doi: 10.1097/00003081-198909000-00019
   PubMed Web of Science ®Google Scholar
• Gallagher JS, Missmer SA, Hornstein MD, et al. Long-term effects of gonadotropin-releasing hormone agonists and add-back in adolescent endometriosis. J Pediatr Adolesc Gynecol. 2018 Aug;31(4):376–381.
   PubMed Web of Science ®Google Scholar
• Barbonetti A, D’Andrea S, Francavilla S. Testosterone replacement therapy. Andrology. 2020 Nov;8(6):1551–1566. doi: 10.1111/andr.12774
   PubMed Web of Science ®Google Scholar
• Tzabazis A, Kori S, Mechanic J, et al. Oxytocin and Migraine Headache. Headache. 2017 May;57(Suppl 2):64–75. doi: 10.1111/head.13082
   PubMedGoogle Scholar
• Warfvinge K, Krause D, Edvinsson L. The distribution of oxytocin and the oxytocin receptor in rat brain: relation to regions active in migraine. J Headache Pain. 2020 Feb 7;21(1):10. doi: 10.1186/s10194-020-1079-8
   PubMed Web of Science ®Google Scholar
• Xin Q, Bai B, Liu W. The analgesic effects of oxytocin in the peripheral and central nervous system. Neurochem Int. 2017 Feb;103:57–64. doi: 10.1016/j.neuint.2016.12.021
   PubMed Web of Science ®Google Scholar
• Amico JA, Seif SM, Robinson AG. Oxytocin in human plasma: correlation with neurophysin and stimulation with estrogen. J Clin Endocrinol Metab. 1981 May;52(5):988–993. doi: 10.1210/jcem-52-5-988
   PubMed Web of Science ®Google Scholar
• Kuwabara Y, Takeda S, Mizuno M, et al. Oxytocin levels in maternal and fetal plasma, amniotic fluid, and neonatal plasma and urine. Arch Gynecol Obstet. 1987;241(1):13–23. doi: 10.1007/BF00931436
   PubMed Web of Science ®Google Scholar
• Grewen KM, Davenport RE, Light KC. An investigation of plasma and salivary oxytocin responses in breast- and formula-feeding mothers of infants. Psychophysiology. 2010 Jul 1;47(4):625–632. doi: 10.1111/j.1469-8986.2009.00968.x
   PubMed Web of Science ®Google Scholar
• Hoshiyama E, Tatsumoto M, Iwanami H, et al. Postpartum migraines: a long-term prospective study. Intern Med. 2012 Nov 15;51(22):3119–3123. doi: 10.2169/internalmedicine.51.8542
   PubMed Web of Science ®Google Scholar
• Wang YL, Yuan Y, Yang J, et al. The interaction between the oxytocin and pain modulation in headache patients. Neuropeptides. 2013 Apr;47(2):93–97.
   PubMed Web of Science ®Google Scholar
• Tzabazis A, Mechanic J, Miller J, et al. Oxytocin receptor: expression in the trigeminal nociceptive system and potential role in the treatment of headache disorders. Cephalalgia. 2016 Sep;36(10):943–950.
   PubMed Web of Science ®Google Scholar
• Al-Karagholi MAM, Kalatharan V, Ghanizada H, et al. Prolactin in headache and migraine: a systematic review of clinical studies. Cephalalgia. 2023 Feb;43(2):3331024221136286. doi: 10.1177/03331024221136286
   Web of Science ®Google Scholar
• Parashar R, Bhalla P, Rai NK, et al. Migraine: is it related to hormonal disturbances or stress? Int J Womens Health. 2014 Oct 24;6:921–925. doi: 10.2147/IJWH.S62922
   PubMedGoogle Scholar
• Alia S. Comparison the serum level of prolactin among patients with chronic and episodic migraine. J Neurol Res. 2013 May 9;3(2):68–72. doi: 10.4021/jnr189w
   Google Scholar
• Guldiken S, Guldiken B, Demir M, et al. Soluble CD40 ligand and prolactin levels in migraine patients during interictal period. J Headache Pain. 2011 Jun;12(3):355–360.
   PubMed Web of Science ®Google Scholar
• Masoud SA, Fakharian E. Serum prolactin and migraine. Ann Saudi Med. 2005 Nov;25(6):489–491. doi: 10.5144/0256-4947.2005.489
   PubMed Web of Science ®Google Scholar
• Hartman N, Voron SC, Hershman JM. Resolution of migraine following bromocriptine treatment of a prolactinoma (pituitary microadenoma). Headache. 1995 Jul;35(7):430–431. doi: 10.1111/j.1526-4610.1995.hed3507430.x
   PubMed Web of Science ®Google Scholar
• Cavestro C, Rosatello A, Marino MP, et al. High prolactin levels as a worsening factor for migraine. J Headache Pain. 2006 Apr;7(2):83–89.
   PubMedGoogle Scholar
• Levy MJ, Matharu MS, Goadsby PJ. Prolactinomas, dopamine agonists and headache: two case reports. Eur J Neurol. 2003 Mar;10(2):169–173. doi: 10.1046/j.1468-1331.2003.00549.x
   PubMed Web of Science ®Google Scholar
• Gazerani P. A link between migraine and prolactin: the way forward. Future Sci OA. 2021 Oct;7(9):FSO748. doi: 10.2144/fsoa-2021-0047
   PubMed Web of Science ®Google Scholar
• Ibrahimi K, Vermeersch S, Danser A, et al. Development of an experimental model to study trigeminal nerve-mediated vasodilation on the human forehead. Cephalalgia. 2014 Jun;34(7):514–522.
   PubMed Web of Science ®Google Scholar
• Glintborg D, Hass Rubin K, Nybo M, et al. Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome. Eur J Endocrinol. 2015 May;172(5):627–638.
   PubMed Web of Science ®Google Scholar
• Pourabolghasem S, Najmi S, Arami MA. Polycystic ovary syndrome and migraine headache, is there any correlation? Eur Neurol. 2009;61(1):42–45. doi: 10.1159/000165349
   PubMed Web of Science ®Google Scholar
• Sam S, Ehrmann DA. Pathogenesis and consequences of disordered sleep in PCOS. Clin Med Insights Reprod Health. 2019 Sep 3;13:1179558119871269. doi: 10.1177/1179558119871269
   Web of Science ®Google Scholar
• Tepper NK, Whiteman MK, Zapata LB, et al. Safety of hormonal contraceptives among women with migraine: a systematic review. Contraception. 2016;94(6):630–640. doi: 10.1016/j.contraception.2016.04.016
   PubMed Web of Science ®Google Scholar
• Hoeger KM, Dokras A, Piltonen T. Update on PCOS: consequences, challenges, and guiding treatment. J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1071–83. doi: 10.1210/clinem/dgaa839
   PubMed Web of Science ®Google Scholar
• Jenabi E, Khazaei S. Endometriosis and migraine headache risk: a meta-analysis. Women & Health. 2020 Sep;60(8):939–945. doi: 10.1080/03630242.2020.1779905
   PubMed Web of Science ®Google Scholar
• van der Vaart JF, Merki-Feld GS. Sex hormone-related polymorphisms in endometriosis and migraine: a narrative review. Womens Health. 2022 Jan;18:17455057221111315. doi: 10.1177/17455057221111315
   Web of Science ®Google Scholar
• Kalaitzopoulos DR, Samartzis N, Kolovos GN, et al. Treatment of endometriosis: a review with comparison of 8 guidelines. BMC Womens Health. 2021 Nov 29;21(1):397. doi: 10.1186/s12905-021-01545-5
   PubMed Web of Science ®Google Scholar
• Yang MH, Wang PH, Wang SJ, et al. Women with endometriosis are more likely to suffer from migraines: a population-based study. PLoS One. 2012 Mar 19;7(3):e33941. doi: 10.1371/journal.pone.0033941
   PubMed Web of Science ®Google Scholar
• Chan Swe N, Ahmed S, Eid M, et al. The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: a literature review. Metabol Open. 2022 Mar;13:100173. doi: 10.1016/j.metop.2022.100173
   PubMedGoogle Scholar
• Gormley GJ, Stoner E, Bruskewitz RC, et al. The effect of finasteride in men with benign prostatic hyperplasia. The finasteride study group. N Engl J Med. 1992 Oct 22;327(17):1185–1191. doi: 10.1056/NEJM199210223271701
   PubMed Web of Science ®Google Scholar
• Check JH, Cohen R. Dihydrotestosterone may contribute to the development of migraine headaches. Clin Exp Obstet Gynecol. 2013;40(2):217–218.
   PubMed Web of Science ®Google Scholar
• Todd CM, Yu A, Lay C, et al. Effect of testosterone therapy on migraine frequency and disability in two transgender patients: a case report. BMJ Case Rep [Internet]. 2023 Jan 24;16(1): e251895. doi: 10.1136/bcr-2022-251895.
   PubMedGoogle Scholar
• Yalinay Dikmen P, Ertas M, Kosak S, et al. Primary headaches among gender dysphoric female-to-male individuals: a cross-sectional survey on gender transition experience. Headache. 2021 Sep;61(8):1194–1206.
   PubMed Web of Science ®Google Scholar
• Wierckx K, Van Caenegem E, Schreiner T, et al. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence. J Sex Med. 2014 Aug;11(8):1999–2011.
   PubMed Web of Science ®Google Scholar
• van Velzen DM, Paldino A, Klaver M, et al. Cardiometabolic effects of testosterone in Transmen and estrogen plus cyproterone acetate in Transwomen. J Clin Endocrinol Metab. 2019 Jun 1;104(6):1937–1947. doi: 10.1210/jc.2018-02138
   PubMed Web of Science ®Google Scholar
• Maraka S, Singh Ospina N, Rodriguez-Gutierrez R, et al. Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2017 Nov 1;102(11):3914–3923. doi: 10.1210/jc.2017-01643
   PubMed Web of Science ®Google Scholar
• Aranda G, Mora M, Hanzu FA, et al. Effects of sex steroids on cardiovascular risk profile in transgender men under gender affirming hormone therapy. Endocrinol Diabetes Nutr (Engl Ed). 2019 Jan 28;66(6):385–392. doi: 10.1016/j.endien.2019.07.001
   PubMed Web of Science ®Google Scholar
• Johnson KS, Conant EF, Soo MS. Molecular subtypes of breast cancer: a review for breast radiologists. J Breast Imaging. 2020 Dec 30;3(1):12–24. doi: 10.1093/jbi/wbaa110
   Google Scholar
• Mathes RW, Malone KE, Daling JR, et al. Migraine in postmenopausal women and the risk of invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3116–3122.
   PubMed Web of Science ®Google Scholar
• Lowry SJ, Malone KE, Cushing-Haugen KL, et al. The risk of breast cancer associated with specific patterns of migraine history. Cancer Causes Control. 2014 Dec;25(12):1707–1715.
   PubMed Web of Science ®Google Scholar
• Ghorbani A, Moradi A, Gookizadeh A, et al. Evaluation of relationship between breast cancer and migraine. Adv Biomed Res. 2015 Jan 6;4(1):14. doi: 10.4103/2277-9175.148297
   PubMedGoogle Scholar
• Ilieva MB, Tiberio P, Torrisi R, et al. Profiling the spectrum of headache disorders on 440 breast cancer patients: highlights on clinical and pathological mechanisms. Biomedicines [Internet]. 2023 Mar 30;11(4): 1059. doi: 10.3390/biomedicines11041059.
   PubMed Web of Science ®Google Scholar
• Tiberio P, Viganò A, Ilieva MB, et al. The role of female Reproductive hormones in the association between migraine and breast cancer: an unanswered question. Biomedicines [Internet]. 2023 Jun 1;11(6): 1613. doi: 10.3390/biomedicines11061613.
   PubMed Web of Science ®Google Scholar
• Granella F, Sances G, Allais G, et al. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia. 2004 Sep;24(9):707–716.
   PubMed Web of Science ®Google Scholar
• Silvestro M, Orologio I, Bonavita S, et al. Effectiveness and safety of CGRP-mAbs in menstrual-related migraine: a real-world experience. Pain Ther. 2021 Dec;10(2):1203–1214. doi: 10.1007/s40122-021-00273-w
   PubMed Web of Science ®Google Scholar
• Verhagen IE, de Vries Lentsch S, van der Arend BWH, et al. Both perimenstrual and nonperimenstrual migraine days respond to anti-calcitonin gene-related peptide (receptor) antibodies. Eur J Neurol. 2023 Jul;30(7):2117–2121. doi: 10.1111/ene.15794
   PubMed Web of Science ®Google Scholar
• Al-Hassany L, Goadsby PJ, Danser AHJ, et al. Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions. Lancet Neurol. 2022 Mar;21(3):284–294.
   PubMed Web of Science ®Google Scholar
• Al-Hassany L, Verdonk P, VanDenbrink AM. Studying sex and gender in neurological disease. Lancet Neurol. 2023 Jan;22(1):32–33. doi: 10.1016/S1474-4422(22)00493-8
   PubMed Web of Science ®Google Scholar
• Szewczyk AK, Ulutas S, Aktürk T, et al. Prolactin and oxytocin: potential targets for migraine treatment. J Headache Pain. 2023 Mar 27;24(1):31. doi: 10.1186/s10194-023-01557-6
   PubMed Web of Science ®Google Scholar
• Favoni V, Giani L, Al-Hassany L, et al. CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP? J Headache Pain. 2019 Mar 12;20(1):27. doi: 10.1186/s10194-019-0979-y
   PubMedGoogle Scholar
• Peters A, Tadi P. Aromatase Inhibitors. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. PMID: 32491779.
   Google Scholar